Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
62 participants
INTERVENTIONAL
2014-04-30
2014-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
P1000/Ca0
P1000/Ca0
22 subjects consume for 8 weeks a beverage enriched with phosphate \[1g phosphorus/d\]
Placebo
all participants consume two weeks before intervention the beverage without phosphate and calcium
P1000/Ca500
P1000/Ca500
22 subjects consume for 8 weeks a beverage enriched with phosphate \[1 g phosphorus/d\] and calcium \[0,5 g calcium\]
Placebo
all participants consume two weeks before intervention the beverage without phosphate and calcium
P1000/Ca1000
P1000/Ca1000
22 subjects consume for 8 weeks a beverage enriched with phosphate \[1 g phosphorus/d\] and calcium \[1 g calcium\]
Placebo
all participants consume two weeks before intervention the beverage without phosphate and calcium
Placebo
P1000/Ca0
22 subjects consume for 8 weeks a beverage enriched with phosphate \[1g phosphorus/d\]
P1000/Ca500
22 subjects consume for 8 weeks a beverage enriched with phosphate \[1 g phosphorus/d\] and calcium \[0,5 g calcium\]
P1000/Ca1000
22 subjects consume for 8 weeks a beverage enriched with phosphate \[1 g phosphorus/d\] and calcium \[1 g calcium\]
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
P1000/Ca0
22 subjects consume for 8 weeks a beverage enriched with phosphate \[1g phosphorus/d\]
P1000/Ca500
22 subjects consume for 8 weeks a beverage enriched with phosphate \[1 g phosphorus/d\] and calcium \[0,5 g calcium\]
P1000/Ca1000
22 subjects consume for 8 weeks a beverage enriched with phosphate \[1 g phosphorus/d\] and calcium \[1 g calcium\]
Placebo
all participants consume two weeks before intervention the beverage without phosphate and calcium
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* physical health
Exclusion Criteria
* kidney diseases
* diabetes mellitus
* metabolic diseases
* osteoporosis
* intake of dietary supplements
* pregnancy and lactation
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Jena
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. Michael Glei
Prof. Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Glei, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
Friedrich-Schiller-University Jena, Institute of Nutrition, Department of Nutritional Toxicology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Friedrich-Schiller-University Jena, Institute of Nutrition, Department of Nutritional Toxicology
Jena, Thuringia, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Trautvetter U, Camarinha-Silva A, Jahreis G, Lorkowski S, Glei M. High phosphorus intake and gut-related parameters - results of a randomized placebo-controlled human intervention study. Nutr J. 2018 Feb 16;17(1):23. doi: 10.1186/s12937-018-0331-4.
Trautvetter U, Jahreis G, Kiehntopf M, Glei M. Consequences of a high phosphorus intake on mineral metabolism and bone remodeling in dependence of calcium intake in healthy subjects - a randomized placebo-controlled human intervention study. Nutr J. 2016 Jan 19;15:7. doi: 10.1186/s12937-016-0125-5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H55-14
Identifier Type: -
Identifier Source: org_study_id